TABLE 4.
Study group | Protein S categorisation |
Total | |||||
---|---|---|---|---|---|---|---|
Protein S < 60% |
Protein S ≥ 60% |
||||||
Mean | n | % | Mean | n | % | ||
Control | - | 0 | 0.0 | - | 59 | 100.0 | 59 |
PLWH on HAART | 45.3% ± 13.24% | 9 | 14.8 | 90% ± 18.5% | 52 | 85.2 | 61 |
HAART-naïve PLWH | 44% ± 11.33% | 15 | 25.9 | 88% ± 17.04% | 43 | 74.1 | 58 |
Total | 44.65% ± 12.29% | 24 | 0.0 | 89% ± 17.77% | 154 | - | 178 |
HAART, highly active antiretroviral treatment; PLWH, people living with HIV.